Observations on Citrobacter species from a tertiary care health center with special reference to multi-drug resistance and presence of CTX-M gene
Author(s) -
Jyotsna Agarwal,
Sneha Mohan,
Ruchi Srivastava,
Mastan Singh
Publication year - 2014
Publication title -
indian journal of pathology and microbiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.217
H-Index - 31
eISSN - 0974-5130
pISSN - 0377-4929
DOI - 10.4103/0377-4929.138746
Subject(s) - citrobacter , cefotaxime , citrobacter freundii , microbiology and biotechnology , drug resistance , multiple drug resistance , multiplex polymerase chain reaction , beta lactamase , cephalosporin , biology , ampicillin , polymerase chain reaction , klebsiella pneumoniae , medicine , enterobacter , antibiotics , gene , escherichia coli , genetics
Citrobacter is an important nosocomial pathogen and its multi-drug resistant (MDR) isolates are increasingly being reported across the globe. They are known to produce extended spectrum beta lactamase (ESBL) and harbor CTX-M gene.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom